• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体腺瘤的全自动分级

Fully automated grading of pituitary adenoma.

作者信息

Da Mutten Raffaele, Zanier Olivier, Bottini Massimo, Baumann Yves, Ciobanu-Caraus Olga, Regli Luca, Serra Carlo, Staartjes Victor E

机构信息

Machine Intelligence in Clinical Neuroscience & Microsurgical Neuroanatomy (MICN) Laboratory, Department of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Department of Computer Science, ETH Zurich, Zurich, Switzerland.

出版信息

Neuroimage Rep. 2025 Jan 29;5(1):100233. doi: 10.1016/j.ynirp.2025.100233. eCollection 2025 Mar.

DOI:10.1016/j.ynirp.2025.100233
PMID:40567882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12172899/
Abstract

BACKGROUND

The Zurich Pituitary Score (ZPS) is an externally validated radiological grading scale to predict the likelihood of gross total resection (GTR) on coronal T1w magnetic resonance imaging of pituitary adenomas. The ZPS is based on the ratio of maximum tumor horizontal diameter and minimum intercarotid distance and on carotid artery encasement. While the interobserver agreement of the ZPS was relatively good, automated grading would be beneficial.

METHODS

A nnU-Net algorithm was trained to segment the manually labeled tumor tissue and the cavernous segment of the internal carotid artery. Subsequently, maximum horizontal tumor diameter and minimum intercarotid distance were extracted. Last, a seed-growing algorithm checked for encasement of the carotid to determine the ZPS.

RESULTS

213 patients were included, of which 128 (60%) had non-functioning adenomas, 49 (23%) a growth-hormone secreting and 19 (9%) a prolactin producing tumor. Accordingly, ZPS gradings were I = 63 (30%), II = 94 (44%), III = 41 (19%) and IV = 15 (7%). Dice score (mean ± standard deviation) for the tumor, left carotid, and right carotid in training validation of 0.78 ± 0.24, 0.62 ± 0.31, 0.62 ± 0.30 and during holdout testing of 0.79 ± 0.24, 0.59 ± 0.32, 0.58 ± 0.33 was reached. After the exclusion of two cases with poor segmentation results, intraclass correlation coefficients [95% CI] for the intercarotid distance, maximum horizontal tumor diameter, and the ZPS ratio of the two measurements were 0.89 [0.80, 0.94], 0.91 [0.82, 0.96], 0.80 [0.66, 0.89] respectively. Cohen's weighted Kappa for the final ZPS grading was 0.79 [0.68, 0.90] and Spearman rank correlation was 0.83.

CONCLUSIONS

We developed and internally validated a machine learning-based method for fully automated grading of the ZPS. Generally, robust segmentation performance was achieved. While ZPS grading generally worked well, human ratings remain superior in many situations. Especially for raters with low experience, our approach offers a solid and objective alternative.

摘要

背景

苏黎世垂体评分(ZPS)是一种经过外部验证的放射学分级量表,用于在垂体腺瘤的冠状位T1加权磁共振成像上预测大体全切(GTR)的可能性。ZPS基于肿瘤最大水平直径与颈内动脉最小间距之比以及颈动脉包绕情况。虽然ZPS的观察者间一致性相对较好,但自动化分级会更有益。

方法

训练一个nnU-Net算法来分割手动标记的肿瘤组织和颈内动脉的海绵窦段。随后,提取肿瘤最大水平直径和颈内动脉最小间距。最后,使用种子生长算法检查颈动脉包绕情况以确定ZPS。

结果

纳入213例患者,其中128例(60%)为无功能腺瘤,49例(23%)为生长激素分泌型肿瘤,19例(9%)为催乳素分泌型肿瘤。相应地,ZPS分级为I级 = 63例(30%),II级 = 94例(44%),III级 = 41例(19%),IV级 = 15例(7%)。在训练验证中,肿瘤、左侧颈动脉和右侧颈动脉的骰子系数(均值±标准差)分别为0.78±0.24、0.62±0.31、0.62±0.30,在保留测试中分别为0.79±0.24、0.59±0.32、0.58±0.33。排除两例分割结果较差的病例后,颈内动脉间距、肿瘤最大水平直径以及两者测量值的ZPS比值的组内相关系数[95%CI]分别为0.89[0.80, 0.94]、0.91[0.82, 0.96]、0.80[0.66, 0.89]。最终ZPS分级 Cohen加权Kappa值为0.79[0.68, 0.90],Spearman等级相关性为0.83。

结论

我们开发并在内部验证了一种基于机器学习的方法,用于ZPS的全自动分级。总体而言,实现了稳健的分割性能。虽然ZPS分级总体效果良好,但在许多情况下人工评分仍更具优势。特别是对于经验不足的评分者,我们的方法提供了一种可靠且客观的替代方案。

相似文献

1
Fully automated grading of pituitary adenoma.垂体腺瘤的全自动分级
Neuroimage Rep. 2025 Jan 29;5(1):100233. doi: 10.1016/j.ynirp.2025.100233. eCollection 2025 Mar.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).针对接受体外受精加卵胞浆内单精子注射(IVF/ICSI)的女性,使用卵巢储备标志物进行个性化促性腺激素剂量选择。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD012693. doi: 10.1002/14651858.CD012693.pub2.
4
Duplex ultrasound for diagnosing symptomatic carotid stenosis in the extracranial segments.双功能超声用于诊断颅外段有症状颈动脉狭窄。
Cochrane Database Syst Rev. 2022 Jul 11;7(7):CD013172. doi: 10.1002/14651858.CD013172.pub2.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
7
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.术中冰冻切片分析用于诊断可疑盆腔肿块中的早期卵巢癌。
Cochrane Database Syst Rev. 2016 Mar 1;3(3):CD010360. doi: 10.1002/14651858.CD010360.pub2.
10
Artificial intelligence for detecting keratoconus.人工智能在圆锥角膜检测中的应用。
Cochrane Database Syst Rev. 2023 Nov 15;11(11):CD014911. doi: 10.1002/14651858.CD014911.pub2.

本文引用的文献

1
Automated volumetric assessment of pituitary adenoma.垂体腺瘤的自动容积评估。
Endocrine. 2024 Jan;83(1):171-177. doi: 10.1007/s12020-023-03529-x. Epub 2023 Sep 25.
2
Automated Koos Classification of Vestibular Schwannoma.前庭神经鞘瘤的自动库斯分类
Front Radiol. 2022 Mar 10;2:837191. doi: 10.3389/fradi.2022.837191. eCollection 2022.
3
Fully automated imaging protocol independent system for pituitary adenoma segmentation: a convolutional neural network-based model on sparsely annotated MRI.基于卷积神经网络的垂体腺瘤分割全自动成像协议独立系统:基于稀疏标注 MRI 的模型。
Neurosurg Rev. 2023 May 10;46(1):116. doi: 10.1007/s10143-023-02014-3.
4
Improved U-Net based on cross-layer connection for pituitary adenoma MRI image segmentation.基于跨层连接的改进U-Net用于垂体腺瘤MRI图像分割
Math Biosci Eng. 2023 Jan;20(1):34-51. doi: 10.3934/mbe.2023003. Epub 2022 Sep 29.
5
Moving toward a standardized diagnostic statement of pituitary adenoma using an information extraction model: a real-world study based on electronic medical records.采用信息提取模型为垂体腺瘤制定标准化诊断陈述:基于电子病历的真实世界研究。
BMC Med Inform Decis Mak. 2022 Dec 7;22(1):319. doi: 10.1186/s12911-022-02031-0.
6
The Medical Segmentation Decathlon.医学分割十项全能
Nat Commun. 2022 Jul 15;13(1):4128. doi: 10.1038/s41467-022-30695-9.
7
Development and Evaluation of Deep Learning-based Automated Segmentation of Pituitary Adenoma in Clinical Task.基于深度学习的临床任务中垂体瘤自动分割的开发与评估。
J Clin Endocrinol Metab. 2021 Aug 18;106(9):2535-2546. doi: 10.1210/clinem/dgab371.
8
nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation.nnU-Net:一种基于深度学习的生物医学图像分割的自配置方法。
Nat Methods. 2021 Feb;18(2):203-211. doi: 10.1038/s41592-020-01008-z. Epub 2020 Dec 7.
9
Array programming with NumPy.使用 NumPy 进行数组编程。
Nature. 2020 Sep;585(7825):357-362. doi: 10.1038/s41586-020-2649-2. Epub 2020 Sep 16.
10
Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist.临床人工智能建模的最低信息要求:MI-CLAIM清单
Nat Med. 2020 Sep;26(9):1320-1324. doi: 10.1038/s41591-020-1041-y.